Spyridon Mastroyannis

569 total citations
31 papers, 233 citations indexed

About

Spyridon Mastroyannis is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Spyridon Mastroyannis has authored 31 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Reproductive Medicine, 12 papers in Obstetrics and Gynecology and 9 papers in Surgery. Recurrent topics in Spyridon Mastroyannis's work include Endometrial and Cervical Cancer Treatments (11 papers), Ovarian cancer diagnosis and treatment (11 papers) and Uterine Myomas and Treatments (5 papers). Spyridon Mastroyannis is often cited by papers focused on Endometrial and Cervical Cancer Treatments (11 papers), Ovarian cancer diagnosis and treatment (11 papers) and Uterine Myomas and Treatments (5 papers). Spyridon Mastroyannis collaborates with scholars based in United States, Italy and Switzerland. Spyridon Mastroyannis's co-authors include Emily Ko, Nawar Latif, Dimitrios Nasioudis, Ashley Haggerty, Benjamin B. Albright, Robert Giuntoli, Mark A. Morgan, Courtney A. Schreiber, Constantine A. Stratakis and Sarita Sonalkar and has published in prestigious journals such as Endocrinology, Annals of Oncology and The Journal of Pediatrics.

In The Last Decade

Spyridon Mastroyannis

29 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Spyridon Mastroyannis United States 9 110 82 61 58 39 31 233
Colleen McCormick United States 7 200 1.8× 66 0.8× 72 1.2× 57 1.0× 30 0.8× 19 293
Svetlana Dragojević-Dikić Serbia 8 128 1.2× 33 0.4× 105 1.7× 27 0.5× 42 1.1× 42 275
Hakan Ozan Türkiye 12 98 0.9× 203 2.5× 28 0.5× 67 1.2× 47 1.2× 37 330
Juria Akasaka Japan 9 143 1.3× 201 2.5× 21 0.3× 56 1.0× 45 1.2× 23 307
Amr K. Elfayomy Saudi Arabia 10 78 0.7× 162 2.0× 100 1.6× 48 0.8× 87 2.2× 19 301
Osamu Tokuyama Japan 9 84 0.8× 20 0.2× 58 1.0× 105 1.8× 25 0.6× 22 275
Grigorios Grimbizis Greece 11 244 2.2× 110 1.3× 91 1.5× 34 0.6× 26 0.7× 27 328
Nabil Abdalla Poland 9 47 0.4× 128 1.6× 53 0.9× 52 0.9× 95 2.4× 21 218
Ahmet Cem İyibozkurt Türkiye 11 202 1.8× 177 2.2× 40 0.7× 66 1.1× 9 0.2× 34 364
Fumitaka Kikkawa Japan 8 219 2.0× 71 0.9× 64 1.0× 135 2.3× 21 0.5× 9 302

Countries citing papers authored by Spyridon Mastroyannis

Since Specialization
Citations

This map shows the geographic impact of Spyridon Mastroyannis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spyridon Mastroyannis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spyridon Mastroyannis more than expected).

Fields of papers citing papers by Spyridon Mastroyannis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spyridon Mastroyannis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spyridon Mastroyannis. The network helps show where Spyridon Mastroyannis may publish in the future.

Co-authorship network of co-authors of Spyridon Mastroyannis

This figure shows the co-authorship network connecting the top 25 collaborators of Spyridon Mastroyannis. A scholar is included among the top collaborators of Spyridon Mastroyannis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spyridon Mastroyannis. Spyridon Mastroyannis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyen, Cam, et al.. (2024). Validation of the Safety and Efficacy of Apixaban as Postoperative Thromboembolism Prophylaxis for Patients with Gynecologic Malignancies. Annals of Surgical Oncology. 31(8). 5102–5110. 2 indexed citations
2.
Cucinella, Giuseppe, Andrea Mariani, Maryam Shahi, et al.. (2022). 2022-RA-987-ESGO Molecular characterization of endometrial cancer with low volume metastasis in the sentinel lymph node: a multicentric international study. International Journal of Gynecological Cancer. 32. A124–A124. 2 indexed citations
3.
Glaser, Gretchen, Olivia D. Lara, Bhavana Pothuri, et al.. (2022). Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry study. Gynecologic Oncology. 167(2). 146–151. 4 indexed citations
4.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Emily Ko, et al.. (2022). Safety of ovarian preservation for premenopausal patients with FIGO stage I grade 2 and 3 endometrioid endometrial adenocarcinoma. International Journal of Gynecological Cancer. 32(11). 1355–1360. 5 indexed citations
5.
Mastroyannis, Spyridon, Aimin Chen, Emily Ko, János L. Tanyi, & Andrea Facciabene. (2022). Antibiotic exposure around first line chemotherapy and survival in ovarian cancer (347). Gynecologic Oncology. 166. S178–S178. 1 indexed citations
6.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Nawar Latif, et al.. (2021). Role of lymphadenectomy for apparent early stage uterine sarcoma; a comprehensive analysis of the National Cancer Database. Surgical Oncology. 38. 101589–101589. 11 indexed citations
7.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Emily Ko, et al.. (2021). Quality of oncologic care and outcomes of patients with endometrial cancer managed at minority-serving hospitals. Gynecologic Oncology. 162. S35–S35. 1 indexed citations
8.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Emily Ko, et al.. (2021). Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival. Gynecologic Oncology. 162. S124–S124. 2 indexed citations
9.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Ashley Haggerty, et al.. (2020). Fertility preserving surgery for high-grade epithelial ovarian carcinoma confined to the ovary. European Journal of Obstetrics & Gynecology and Reproductive Biology. 248. 63–70. 9 indexed citations
10.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Ashley Haggerty, Emily Ko, & Nawar Latif. (2020). Ovarian Sertoli-Leydig and granulosa cell tumor: comparison of epidemiology and survival outcomes. Archives of Gynecology and Obstetrics. 302(2). 481–486. 8 indexed citations
11.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Nawar Latif, & Emily Ko. (2020). Trends in the surgical management of malignant ovarian germcell tumors. Gynecologic Oncology. 157(1). 89–93. 13 indexed citations
12.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Nawar Latif, et al.. (2020). Effect of bilateral salpingo-oophorectomy on the overall survival of premenopausal patients with stage I low-grade endometrial stromal sarcoma; a National Cancer Database analysis. Gynecologic Oncology. 157(3). 634–638. 13 indexed citations
13.
Albright, Benjamin B., et al.. (2019). Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy. Obstetrics and Gynecology. 135(1). 12–23. 36 indexed citations
14.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Giovanni Sisti, et al.. (2019). Increased Risk of Breast and Uterine Cancer Among Women With Ovarian Granulosa Cell Tumors. Anticancer Research. 39(9). 4971–4975. 8 indexed citations
15.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Benjamin B. Albright, et al.. (2018). Adjuvant chemotherapy for stage I ovarian clear cell carcinoma: Patterns of use and outcomes. Gynecologic Oncology. 150(1). 14–18. 28 indexed citations
16.
Mastroyannis, Spyridon, et al.. (2018). Is There a “July Effect” in Oncologic and Benign Gynecologic Surgery? [17Q]. Obstetrics and Gynecology. 131(1). 189S–189S. 2 indexed citations
17.
Nasioudis, Dimitrios, Spyridon Mastroyannis, Emily Ko, & Nawar Latif. (2018). Does tumor grade influence the rate of lymph node metastasis in apparent early stage ovarian cancer?. Archives of Gynecology and Obstetrics. 298(1). 179–182. 17 indexed citations
18.
Hannah‐Shmouni, Fady, Andreas Moraitis, Fábio R. Faucz, et al.. (2017). Successful Treatment of Estrogen Excess in Primary Bilateral Macronodular Adrenocortical Hyperplasia with Leuprolide Acetate. Hormone and Metabolic Research. 50(2). 124–132. 8 indexed citations
19.
20.
Lodish, Maya, Spyridon Mastroyannis, Ninet Sinaii, Sosipatros A. Boikos, & Constantine A. Stratakis. (2012). Known VDR polymorphisms are not associated with bone mineral density measures in pediatric Cushing disease. Journal of Pediatric Endocrinology and Metabolism. 25(1-2). 221–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colleen McCormick Breakdown of academic impact, for papers by Svetlana Dragojević-Dikić Breakdown of academic impact, for papers by Hakan Ozan Breakdown of academic impact, for papers by Juria Akasaka Breakdown of academic impact, for papers by Amr K. Elfayomy Breakdown of academic impact, for papers by Osamu Tokuyama Breakdown of academic impact, for papers by Grigorios Grimbizis Breakdown of academic impact, for papers by Nabil Abdalla Breakdown of academic impact, for papers by Ahmet Cem İyibozkurt Breakdown of academic impact, for papers by Fumitaka Kikkawa
Rankless by CCL
2026